Class information for:
Level 2: ANTIDEPRESSANTS//AGOMELATINE//MOCLOBEMIDE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
667 12573 32.9 61%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
184 51606 BIPOLAR DISORDERS//ELECTROCONVULSIVE THERAPY//JOURNAL OF CLINICAL PSYCHIATRY

Classes in level below (level 1)


ID, lev. below Publications Label for level below
2378 2196 NORFLUOXETINE//FLUVOXAMINE//CITALOPRAM
6290 1439 LITHIUM AUGMENTATION//RESISTANT DEPRESSION//DEP S CLIN PROGRAM
8281 1199 NORTRIPTYLINE//DESMETHYLCLOMIPRAMINE//DOXEPIN
8771 1150 VENLAFAXINE//MILNACIPRAN//ESCITALOPRAM
10182 1021 MOCLOBEMIDE//ATYPICAL DEPRESSION//BROFAROMINE
12037 871 TRAZODONE//DESMETHYLMIANSERIN//ETOPERIDONE
15807 622 ACTIVATION SYNDROME//RISK EVALUATION AND MITIGATION STRATEGIES//REGULATORY ACTIONS
17625 526 SEROTONIN SYNDROME//SEROTONIN TOXICITY//COMPLICATIONS SEROTONIN SYNDROME
18097 504 BROMATOL NUTR DIETET//ESTADES PRACT TUTELADES UNIT//CLIN PHARMACOL MED CARE
18612 478 DISCONTINUATION SYNDROME//DISCONTINUATION SYMPTOMS//WITHDRAWAL REACTIONS
19597 433 BUPROPION//HYDROXYBUPROPION//WELLBUTRIN
21772 348 INTRAMOLECULAR BARBIER REACTION//NOREPINEPHRINE POTENTIATOR//REDUCTIVE N METHYLATION
21868 345 MIRTAZAPINE//ORG 3770//C 11MIRTAZAPINE
22240 331 REBOXETINE//SELECTIVE NOREPINEPHRINE REUPTAKE INHIBITOR//SELECTIVE NRI
22834 311 BLEEDING ABNORMALITIES//VENOUS THROMBOSIS AND EMBOLISM//ABORATING TRAINING PHARMACOEPIDEMIO
24904 248 AGOMELATINE//MELATONERGIC RECEPTORS//S 20098
26324 212 GRP PSYCHOSOMAT REHABIL//PARTICIPATION DISORDERS//WORKPLACE PHOBIA
27981 177 META NISOLDIPINE//VOLTAGE ACTIVATED//M NISOLDIPINE
28836 162 ATOMOXETINE HYDROCHLORIDE//4 HYDROXYATOMOXETINE//ANTI DEPRESSANT DRUG

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ANTIDEPRESSANTS Author keyword 131 17% 6% 725
2 AGOMELATINE Author keyword 125 62% 1% 128
3 MOCLOBEMIDE Author keyword 113 53% 1% 151
4 VENLAFAXINE Author keyword 112 34% 2% 267
5 MIRTAZAPINE Author keyword 109 41% 2% 208
6 SEROTONIN SYNDROME Author keyword 108 53% 1% 143
7 INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY Journal 98 22% 3% 391
8 JOURNAL OF CLINICAL PSYCHIATRY Journal 97 12% 6% 783
9 FLUOXETINE Author keyword 74 17% 3% 406
10 ESCITALOPRAM Author keyword 72 34% 1% 175

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ANTIDEPRESSANTS 131 17% 6% 725 Search ANTIDEPRESSANTS Search ANTIDEPRESSANTS
2 AGOMELATINE 125 62% 1% 128 Search AGOMELATINE Search AGOMELATINE
3 MOCLOBEMIDE 113 53% 1% 151 Search MOCLOBEMIDE Search MOCLOBEMIDE
4 VENLAFAXINE 112 34% 2% 267 Search VENLAFAXINE Search VENLAFAXINE
5 MIRTAZAPINE 109 41% 2% 208 Search MIRTAZAPINE Search MIRTAZAPINE
6 SEROTONIN SYNDROME 108 53% 1% 143 Search SEROTONIN+SYNDROME Search SEROTONIN+SYNDROME
7 FLUOXETINE 74 17% 3% 406 Search FLUOXETINE Search FLUOXETINE
8 ESCITALOPRAM 72 34% 1% 175 Search ESCITALOPRAM Search ESCITALOPRAM
9 ANTIDEPRESSANT 67 13% 4% 474 Search ANTIDEPRESSANT Search ANTIDEPRESSANT
10 CITALOPRAM 64 23% 2% 241 Search CITALOPRAM Search CITALOPRAM

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 SEROTONIN REUPTAKE INHIBITORS 381 25% 10% 1296
2 FLUOXETINE 217 19% 8% 1028
3 TRICYCLIC ANTIDEPRESSANTS 192 32% 4% 497
4 ANTIDEPRESSANTS 187 19% 7% 910
5 VENLAFAXINE 136 35% 3% 316
6 REFRACTORY DEPRESSION 131 52% 1% 181
7 STAR ASTERISK D 127 34% 2% 304
8 IMIPRAMINE 100 20% 4% 460
9 PAROXETINE 92 21% 3% 399
10 TREATMENT REFRACTORY DEPRESSION 89 81% 0% 54

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY 98 22% 3% 391
2 JOURNAL OF CLINICAL PSYCHIATRY 97 12% 6% 783
3 JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 65 15% 3% 391
4 PSYCHOPHARMAKOTHERAPIE 29 23% 1% 113
5 PHARMACOPSYCHIATRY 26 11% 2% 218
6 INTERNATIONAL PHARMACOPSYCHIATRY 8 26% 0% 28
7 PHARMACOPSYCHIATRIA 4 17% 0% 20
8 PRIMARY CARE PSYCHIATRY 1 10% 0% 10
9 COMMUNICATIONS IN PSYCHOPHARMACOLOGY 1 12% 0% 8
10 REVIEWS IN CONTEMPORARY PHARMACOTHERAPY 1 10% 0% 9

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis 2009 538 105 77%
Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review 2015 6 54 74%
Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials 2009 184 25 84%
Comparative Efficacy, Acceptability, and Tolerability of Augmentation Agents in Treatment-Resistant Depression: Systematic Review and Network Meta-Analysis 2015 3 77 73%
Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability 2000 408 121 92%
If at First You Don't Succeed A Review of the Evidence for Antidepressant Augmentation, Combination and Switching Strategies 2011 67 73 82%
The serotonin syndrome 2005 488 32 56%
Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression 2015 3 73 56%
Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder An Updated Meta-analysis 2011 69 114 75%
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011 2011 199 654 25%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DEP S CLIN PROGRAM 36 28% 0.9% 108
2 EPIDEMIOL DATA 18 28% 0.4% 55
3 INT HLTH ECON EPIDEMIOL 12 86% 0.0% 6
4 MOOD DISORDERS PROGRAM CLIN 10 58% 0.1% 11
5 UNITE BIOCHIM PSYCHOPHARMACOL CLIN 8 35% 0.2% 19
6 GRP PSYCHOSOMAT REHABIL 8 33% 0.2% 19
7 HERGEST UNIT 7 37% 0.1% 16
8 BROMATOL NUTR DIETET 6 45% 0.1% 10
9 DRUG UTILISAT SUBCOMM 4 75% 0.0% 3
10 ESTADES PRACT TUTELADES UNIT 4 75% 0.0% 3

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000017829 GENERALIZED ANXIETY DISORDER//HYPOCHONDRIASIS//PERSONALITY DISORDER
2 0.0000011857 BIPOLAR DISORDERS//JOURNAL OF AFFECTIVE DISORDERS//MANIA
3 0.0000011805 RISPERIDONE//CLOZAPINE//OLANZAPINE
4 0.0000011323 SEROTONIN//5 HT1A RECEPTOR//5 HT1A RECEPTORS
5 0.0000010896 OLFACTORY BULBECTOMY//CHRONIC MILD STRESS//LEARNED HELPLESSNESS
6 0.0000009816 POISONING//JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY//POISON CONTROL CENTERS
7 0.0000009683 RASAGILINE//SELEGILINE//DEPRENYL
8 0.0000009032 ELECTROCONVULSIVE THERAPY//JOURNAL OF ECT//CONVULSIVE THERAPY
9 0.0000006842 DIMEBON//DIMEBOLIN//REMOXIPRIDE
10 0.0000006755 BENZODIAZEPINES//ZOLPIDEM//ZOPICLONE